bisphosphonates

A Brief Update of the Current Landscape of Bone Targeted Therapies for Prostate Cancer

Prostate cancer tends to metastasize to bones as opposed to soft tissue and other organs. We have no idea why it does have a preference for bone, but it does. Developing bone metastases in prostrate cancer is a very strong negative prognostic indicator. Prostate cancer’s tendency to favor bone over soft tissue causes significant morbidity [...]

By Malecare|2016-10-14T13:14:25-04:00October 14th, 2016|Advanced Prostate Cancer, Alpharadin (radium-223), bisphosphonates, Bone Metastases, Bones and Prostate Cancer, Drugs & Treatments, Survival, Uncategorized, Understanding Advanced Prostate Cancer, Xgeva, Xofigo, Zometa|2 Comments

Radium-223 When Given In Combinations May Improve Survival in mCRPC

As I have said before, the next big step in the clinical care of men with prostate cancer will be in not in the development of a new drug, but in our growing knowledge of how to sequence and combine our new drugs. Today’s post provides just one example of this new type of breakthrough [...]

By Malecare|2020-02-04T11:45:46-05:00September 26th, 2015|Advanced Prostate Cancer, bisphosphonates, Bone Metastases, Bones and Prostate Cancer, Chemotherapy, Clinical Trials & Re